{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:01:08Z","timestamp":1785438068851,"version":"3.56.0"},"reference-count":67,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,1]]},"DOI":"10.2967\/jnumed.126.272805","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:46:57Z","timestamp":1785437217000},"page":"jnumed.126.272805","source":"Crossref","is-referenced-by-count":0,"title":["Neuroinflammatory PET in Epilepsy: Prospects for Epileptogenic Zone Localization and Presurgical Planning"],"prefix":"10.2967","author":[{"given":"Callum","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Jupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Vivash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2026073007200747000_jnumed.126.272805v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002033420503"},{"key":"2026073007200747000_jnumed.126.272805v1.2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17194"},{"key":"2026073007200747000_jnumed.126.272805v1.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209304"},{"key":"2026073007200747000_jnumed.126.272805v1.4","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31827d1161"},{"key":"2026073007200747000_jnumed.126.272805v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106249"},{"key":"2026073007200747000_jnumed.126.272805v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00727-5"},{"key":"2026073007200747000_jnumed.126.272805v1.7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1217451"},{"key":"2026073007200747000_jnumed.126.272805v1.8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/brain\/awac293","article-title":"\u2018Hippocampal innate inflammatory gliosis only\u2019 in pharmacoresistant temporal lobe epilepsy","volume":"146","author":"Grote","year":"2023","journal-title":"Brain."},{"key":"2026073007200747000_jnumed.126.272805v1.9","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.3390\/ijms25084161","article-title":"Neuroinflammation and epilepsy: from pathophysiology to therapies based on repurposing drugs","volume":"25","author":"Sanz","year":"2024","journal-title":"Int J Mol Sci."},{"key":"2026073007200747000_jnumed.126.272805v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114786"},{"key":"2026073007200747000_jnumed.126.272805v1.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2010.00572.x"},{"key":"2026073007200747000_jnumed.126.272805v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/epi.15967"},{"key":"2026073007200747000_jnumed.126.272805v1.13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/epi.18182","article-title":"TSPO\u2010PET in pre\u2010surgical evaluations: correlation of neuroinflammation and SEEG epileptogenicity mapping in drug\u2010resistant focal epilepsy","volume":"66","author":"Kilmer","year":"2025","journal-title":"Epilepsia."},{"key":"2026073007200747000_jnumed.126.272805v1.14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/brainsci16020246","article-title":"Exploring the role of TSPO-PET imaging among MRI-negative patients with temporal lobe epilepsy: from the perspective of heterogeneity","volume":"16","author":"Chen","year":"2026","journal-title":"Brain Sci."},{"key":"2026073007200747000_jnumed.126.272805v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40937-z"},{"key":"2026073007200747000_jnumed.126.272805v1.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.079459"},{"key":"2026073007200747000_jnumed.126.272805v1.17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaneurol.2015.0941","article-title":"Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein","volume":"72","author":"Gershen","year":"2015","journal-title":"JAMA Neurol."},{"key":"2026073007200747000_jnumed.126.272805v1.18","doi-asserted-by":"crossref","first-page":"e1893","DOI":"10.1212\/WNL.0000000000207811","article-title":"[18F]DPA-714 PET imaging in the presurgical evaluation of patients with drug-resistant focal epilepsy","volume":"101","author":"Cheval","year":"2023","journal-title":"Neurology."},{"key":"2026073007200747000_jnumed.126.272805v1.19","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/epi.18351","article-title":"Emerging translocator protein-positron emission tomographic imaging improves detection of focal cortical dysplasia","volume":"66","author":"Qiao","year":"2025","journal-title":"Epilepsia."},{"key":"2026073007200747000_jnumed.126.272805v1.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.20.6385"},{"key":"2026073007200747000_jnumed.126.272805v1.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001616"},{"key":"2026073007200747000_jnumed.126.272805v1.22","doi-asserted-by":"crossref","first-page":"102701","DOI":"10.1016\/j.nicl.2021.102701","article-title":"TSPO PET upregulation predicts epileptic phenotype at disease onset independently from chronic TSPO expression in a rat model of temporal lobe epilepsy","volume":"31","author":"Bertoglio","year":"2021","journal-title":"Neuroimage Clin."},{"key":"2026073007200747000_jnumed.126.272805v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2014.55"},{"key":"2026073007200747000_jnumed.126.272805v1.24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12974-023-02749-2","article-title":"[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data","volume":"20","author":"Ballweg","year":"2023","journal-title":"J Neuroinflammation."},{"key":"2026073007200747000_jnumed.126.272805v1.25","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1093\/brain\/awad279","article-title":"Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms","volume":"146","author":"Koshimori","year":"2023","journal-title":"Brain."},{"key":"2026073007200747000_jnumed.126.272805v1.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.244400"},{"key":"2026073007200747000_jnumed.126.272805v1.27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12264-020-00573-9","article-title":"Characterization of the expression of the ATP-gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse","volume":"36","author":"Morgan","year":"2020","journal-title":"Neurosci Bull."},{"key":"2026073007200747000_jnumed.126.272805v1.28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41181-025-00345-8","article-title":"Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers","volume":"10","author":"Rui","year":"2025","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026073007200747000_jnumed.126.272805v1.29","doi-asserted-by":"crossref","unstructured":"Smith AM Park TIH Aalderink M . Distinct characteristics of microglia from neurogenic and non-neurogenic regions of the human brain in patients with mesial temporal lobe epilepsy. Front Cell Neurosci. 2022;16.","DOI":"10.3389\/fncel.2022.1047928"},{"key":"2026073007200747000_jnumed.126.272805v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.05.058"},{"key":"2026073007200747000_jnumed.126.272805v1.31","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x16685105"},{"key":"2026073007200747000_jnumed.126.272805v1.32","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.bmcl.2017.04.052","article-title":"Synthesis and preliminary biological evaluation of [11C]methyl (2-amino-5-(benzylthio)thiazolo[4,5-D]pyrimidin-7-yl)-D-leucinate for the fractalkine receptor (CX3CR1)","volume":"27","author":"Gao","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"2026073007200747000_jnumed.126.272805v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.11.009"},{"key":"2026073007200747000_jnumed.126.272805v1.34","first-page":"209","article-title":"[18F]JHU16907 for PET imaging of MER tyrosine kinase (MERTK)","volume":"58","author":"Horti","year":"2017","journal-title":"J Nucl Med."},{"key":"2026073007200747000_jnumed.126.272805v1.35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27051689"},{"key":"2026073007200747000_jnumed.126.272805v1.36","unstructured":"Song Z Li Y Feng S . Preclinical evaluation of [18F]P4B-2412 as phosphodiesterase 4B radioligand for positron emission tomography imaging [preprint]. bioRxiv . January 16, 2025."},{"key":"2026073007200747000_jnumed.126.272805v1.37","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.biopsych.2023.02.280","article-title":"40. Novel pet ligand [18F]PF974 can measure inflammatory activation of phosphodiesterase-4B (PDE4B) in rat brain [abstract]","volume":"93","author":"Knoer","year":"2023","journal-title":"Biol Psychiatry."},{"key":"2026073007200747000_jnumed.126.272805v1.38","doi-asserted-by":"publisher","DOI":"10.1021\/cn2000525"},{"key":"2026073007200747000_jnumed.126.272805v1.39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41181-025-00338-7","article-title":"Efficient one-pot radiosynthesis of the 11C-labeled aquaporin-4 inhibitor TGN-020","volume":"10","author":"Kawamura","year":"2025","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026073007200747000_jnumed.126.272805v1.40","doi-asserted-by":"publisher","DOI":"10.1002\/syn.21541"},{"key":"2026073007200747000_jnumed.126.272805v1.41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acschemneuro.5b00319","article-title":"Synthesis and evaluation of [18F]RAGER: a first generation small-molecule PET radioligand targeting the receptor for advanced glycation endproducts","volume":"7","author":"Cary","year":"2016","journal-title":"ACS Chem Neurosci."},{"key":"2026073007200747000_jnumed.126.272805v1.42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jpha.2020.07.009","article-title":"Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)","volume":"10","author":"Drake","year":"2020","journal-title":"J Pharm Anal."},{"key":"2026073007200747000_jnumed.126.272805v1.43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/fmc-2019-0329","article-title":"Radiolabeling of [11C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [11C]CO2-to-[11C]CO chemical conversion","volume":"12","author":"Luzi","year":"2020","journal-title":"Future Med Chem."},{"key":"2026073007200747000_jnumed.126.272805v1.44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nucmedbio.2014.03.025","article-title":"Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2)","volume":"41","author":"Cole","year":"2014","journal-title":"Nucl Med Biol."},{"key":"2026073007200747000_jnumed.126.272805v1.45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/ph16020194","article-title":"In vivo imaging and kinetic modeling of novel glycogen synthase kinase-3 radiotracers [11C]OCM-44 and [18F]OCM-50 in non-human primates","volume":"16","author":"Smart","year":"2023","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026073007200747000_jnumed.126.272805v1.46","first-page":"491","article-title":"Discovery of [11C]PF-367 for neuroimaging of glycogen synthase kinase 3","volume":"56","author":"Liang","year":"2015","journal-title":"J Nucl Med."},{"key":"2026073007200747000_jnumed.126.272805v1.47","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/acschemneuro.6b00376","article-title":"Radiosynthesis and in vivo evaluation of [11C]A1070722, a high affinity GSK-3 PET tracer in primate brain","volume":"8","author":"Prabhakaran","year":"2017","journal-title":"ACS Chem Neurosci."},{"key":"2026073007200747000_jnumed.126.272805v1.48","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.116228"},{"key":"2026073007200747000_jnumed.126.272805v1.49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.33696\/Signaling.6.134","article-title":"Monoamine oxidase B in astrocytic GABA synthesis: a central mechanism in neurodegeneration and neuroinflammation","volume":"6","author":"Naffaa","year":"2025","journal-title":"J Cell Signal."},{"key":"2026073007200747000_jnumed.126.272805v1.50","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1528-1157.1995.tb01051.x","article-title":"Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy","volume":"36","author":"Kumlien","year":"1995","journal-title":"Epilepsia."},{"key":"2026073007200747000_jnumed.126.272805v1.51","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/epi.16353","article-title":"Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers","volume":"60","author":"Bascu\u00f1ana","year":"2019","journal-title":"Epilepsia."},{"key":"2026073007200747000_jnumed.126.272805v1.52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11064-025-04502-y","article-title":"The Multifaceted role of P2X7R in microglia and astrocytes","volume":"50","author":"Bedetta","year":"2025","journal-title":"Neurochem Res."},{"key":"2026073007200747000_jnumed.126.272805v1.53","first-page":"5433","article-title":"Increased expression of the P2X7 receptor in temporal lobe epilepsy: animal models and clinical evidence","volume":"19","author":"Song","year":"2019","journal-title":"Mol Med Rep."},{"key":"2026073007200747000_jnumed.126.272805v1.54","doi-asserted-by":"crossref","first-page":"109303","DOI":"10.1016\/j.neuropharm.2022.109303","article-title":"More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy","volume":"222","author":"Wong","year":"2023","journal-title":"Neuropharmacology."},{"key":"2026073007200747000_jnumed.126.272805v1.55","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/acschemneuro.2c00557","article-title":"Longitudinal positron emission tomography imaging with P2X7 receptor-specific radioligand 18F-FTTM in a kainic acid rat model of temporal lobe epilepsy","volume":"13","author":"Fu","year":"2022","journal-title":"ACS Chem Neurosci."},{"key":"2026073007200747000_jnumed.126.272805v1.56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/epi.17484","article-title":"Increased uptake of the P2X7 receptor radiotracer 18F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice","volume":"64","author":"Morgan","year":"2023","journal-title":"Epilepsia."},{"key":"2026073007200747000_jnumed.126.272805v1.57","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16956"},{"key":"2026073007200747000_jnumed.126.272805v1.58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-026-02224-y","article-title":"Spatiotemporal transcriptomic mapping reveals region-specific glial activation and astrocyte shifts in epileptogenesis beyond the hippocampus","volume":"14","author":"Dufour","year":"2026","journal-title":"Acta Neuropathol Commun."},{"key":"2026073007200747000_jnumed.126.272805v1.59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812155116"},{"key":"2026073007200747000_jnumed.126.272805v1.60","doi-asserted-by":"crossref","first-page":"108992","DOI":"10.1016\/j.nucmedbio.2025.108992","article-title":"First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115","volume":"142-143","author":"Chao","year":"2025","journal-title":"Nucl Med Biol."},{"key":"2026073007200747000_jnumed.126.272805v1.61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/ijms24021374","article-title":"Spotlight on P2X7 receptor PET imaging: a bright target or a failing star?","volume":"24","author":"Schmidt","year":"2023","journal-title":"Int J Mol Sci."},{"key":"2026073007200747000_jnumed.126.272805v1.62","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00259-019-04369-6","article-title":"[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson\u2019s disease and healthy volunteers","volume":"46","author":"Van Weehaeghe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026073007200747000_jnumed.126.272805v1.63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010019"},{"key":"2026073007200747000_jnumed.126.272805v1.64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nucmedbio.2011.09.005","article-title":"Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer","volume":"39","author":"Evens","year":"2012","journal-title":"Nucl Med Biol."},{"key":"2026073007200747000_jnumed.126.272805v1.65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fnins.2016.00431","article-title":"Synthesis, biodistribution and in vitro evaluation of brain permeable high affinity type 2 cannabinoid receptor agonists [11C]MA2 and [18F]MA3","volume":"10","author":"Ahamed","year":"2016","journal-title":"Front Neurosci."},{"key":"2026073007200747000_jnumed.126.272805v1.66","doi-asserted-by":"crossref","first-page":"113822","DOI":"10.1016\/j.ejmech.2021.113822","article-title":"Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease","volume":"226","author":"Wong","year":"2021","journal-title":"Eur J Med Chem."},{"key":"2026073007200747000_jnumed.126.272805v1.67","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.263838"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:47:02Z","timestamp":1785437222000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":67,"alternative-id":["10.2967\/jnumed.126.272805"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272805","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}